Suivre
Helen Y Chu
Helen Y Chu
Associate Professor of Medicine, University of Washington
Adresse e-mail validée de uw.edu - Page d'accueil
Titre
Citée par
Citée par
Année
Remdesivir for the treatment of Covid-19
JH Beigel, KM Tomashek, LE Dodd, AK Mehta, BS Zingman, AC Kalil, ...
New England Journal of Medicine 383 (19), 1813-1826, 2020
66942020
Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies
AJ Greaney, AN Loes, KHD Crawford, TN Starr, KD Malone, HY Chu, ...
Cell host & microbe, 2021
9682021
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift
E Cameroni, JE Bowen, LE Rosen, C Saliba, SK Zepeda, K Culap, ...
Nature 602 (7898), 664-670, 2022
7722022
Sequelae in adults at 6 months after COVID-19 infection
JK Logue, NM Franko, DJ McCulloch, D McDonald, A Magedson, CR Wolf, ...
JAMA network open 4 (2), e210830-e210830, 2021
6572021
Protocol and reagents for pseudotyping lentiviral particles with SARS-CoV-2 spike protein for neutralization assays
KHD Crawford, R Eguia, AS Dingens, AN Loes, KD Malone, CR Wolf, ...
Viruses 12 (5), 513, 2020
5472020
Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity
E Shrock, E Fujimura, T Kula, RT Timms, IH Lee, Y Leng, ML Robinson, ...
Science 370 (6520), eabd4250, 2020
4582020
Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein
SJ Zost, P Gilchuk, RE Chen, JB Case, JX Reidy, A Trivette, RS Nargi, ...
Nature medicine 26 (9), 1422-1427, 2020
3852020
Analysis of a SARS-CoV-2-infected individual reveals development of potent neutralizing antibodies with limited somatic mutation
E Seydoux, LJ Homad, AJ MacCamy, KR Parks, NK Hurlburt, ...
Immunity 53 (1), 98-105. e5, 2020
3452020
The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates
NI Mazur, D Higgins, MC Nunes, JA Melero, AC Langedijk, N Horsley, ...
The Lancet Infectious Diseases 18 (10), e295-e311, 2018
345*2018
Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2
AC Walls, B Fiala, A Schäfer, S Wrenn, MN Pham, M Murphy, ...
Cell 183 (5), 1367-1382. e17, 2020
3272020
Distinct early serological signatures track with SARS-CoV-2 survival
C Atyeo, S Fischinger, T Zohar, MD Slein, J Burke, C Loos, DJ McCulloch, ...
Immunity 53 (3), 524-532. e4, 2020
3012020
Multiple early factors anticipate post-acute COVID-19 sequelae
Y Su, D Yuan, DG Chen, RH Ng, K Wang, J Choi, S Li, S Hong, R Zhang, ...
Cell 185 (5), 881-895. e20, 2022
2892022
Cryptic transmission of SARS-CoV-2 in Washington state
T Bedford, AL Greninger, P Roychoudhury, LM Starita, M Famulare, ...
Science 370 (6516), 571-575, 2020
2462020
Dynamics of neutralizing antibody titers in the months after severe acute respiratory syndrome coronavirus 2 infection
KHD Crawford, AS Dingens, R Eguia, CR Wolf, N Wilcox, JK Logue, ...
The Journal of infectious diseases 223 (2), 197-205, 2021
2452021
Genomic surveillance reveals multiple introductions of SARS-CoV-2 into Northern California
X Deng, W Gu, S Federman, L Du Plessis, OG Pybus, NR Faria, C Wang, ...
Science 369 (6503), 582-587, 2020
2272020
Year-round influenza immunisation during pregnancy in Nepal: a phase 4, randomised, placebo-controlled trial
MC Steinhoff, J Katz, JA Englund, SK Khatry, L Shrestha, J Kuypers, ...
The Lancet infectious diseases 17 (9), 981-989, 2017
1992017
Global disease burden estimates of respiratory syncytial virus–associated acute respiratory infection in older adults in 2015: a systematic review and meta-analysis
T Shi, A Denouel, AK Tietjen, I Campbell, E Moran, X Li, H Campbell, ...
The Journal of infectious diseases 222 (Supplement_7), S577-S583, 2020
1812020
Molecular basis of immune evasion by the Delta and Kappa SARS-CoV-2 variants
M McCallum, AC Walls, KR Sprouse, JE Bowen, LE Rosen, HV Dang, ...
Science 374 (6575), 1621-1626, 2021
1722021
COVID-19 outbreak among three affiliated homeless service sites—King County, Washington, 2020
FA Tobolowsky, E Gonzales, JL Self, CY Rao, R Keating, GE Marx, ...
Morbidity and Mortality Weekly Report 69 (17), 523, 2020
1662020
Antibodies elicited by mRNA-1273 vaccination bind more broadly to the receptor binding domain than do those from SARS-CoV-2 infection
AJ Greaney, AN Loes, LE Gentles, KHD Crawford, TN Starr, KD Malone, ...
Science translational medicine 13 (600), eabi9915, 2021
154*2021
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20